NCT01063907 2024-04-25
A Study of KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma
Kyowa Kirin Co., Ltd.
Phase 1/2 Completed
Kyowa Kirin Co., Ltd.
Bristol-Myers Squibb
Cancer Research UK
University of Pennsylvania
Pharmacyclics LLC.